High On-Treatment Platelet Reactivity to Both Aspirin and Clopidogrel Is Associated With The Highest Risk of Adverse Events Following Percutaneous Coronary Intervention

Study Questions:

What is the incidence of dual high on-treatment platelet reactivity (DAPR) and its impact on clinical outcome?